Aridis Pharmaceuticals, Inc. (ARDS)

Aridis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Net Income	-30.75	-42.28	-21.92	-28.99	-22.11
Depreciation & Amortization	0.49	0.44	0.34	0.34	0.28
Share-Based Compensation	1.48	2.25	2.13	2.01	0
Other Operating Activities	-0.34	16.66	-1.02	18.48	-2.45
Operating Cash Flow	-29.13	-22.94	-20.48	-8.16	-24.27
Capital Expenditures	-0.08	-0.53	-0.37	-0.17	-0.68
Acquisitions	0	0	0	0	-1
Change in Investments	-	-	-	-	-1
Other Investing Activities	-	-	-	-	1
Investing Cash Flow	-0.08	-0.53	-0.37	-0.17	-1.68
Common Stock Issued	12.61	29.72	7.95	4.96	25.08
Other Financing Activities	2.17	5.01	0.73	0.04	0.01
Financing Cash Flow	14.78	34.72	8.68	4.99	25.09
Net Cash Flow	-14.43	11.25	-12.17	-3.34	-0.86
Free Cash Flow	-29.21	-23.47	-20.84	-8.33	-24.95
Free Cash Flow Margin	-	-	-2084.30%	-815.36%	-904.90%
Free Cash Flow Per Share	-1.56	-1.91	-2.27	-0.99	-7.93

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.